Award and trophy are extensively used in a lot of fields today. Trophies, awards, medals, and plaques serve as ideal incentives that will enhance the morale and productivity of the recipients. Specially inside the sports planet, trophies are known because lengthy. There is a massive trend of corporates searching for the specific award and trophy…
Tag: pharmacy
2020 EXHIBITS WINS NINE PRESTIGIOUS WORLD EXHIBITION AWARDS
In this world of tremendous flux and change, it is thrilling and a tremendous honor to learn that 2020 Exhibits has won Gold, Silver, and Bronze awards across nine categories at the World Exhibition Stand Awards (WESA). WESA celebrates the very best in exhibit design and experience across the globe. As the second annual WESA,…
Patients need to pay less for their medicines. States can help.
No one should struggle to afford the medicines they need. Unfortunately, some patients continue to bear more of their medicine costs at the pharmacy counter. Patients with deductibles have seen their out-of-pocket costs for brand medicines in some areas increase 50% since 2015. Today, more than half of every dollar spent on brand medicines goes to payers, middlemen,…
Be the Change: Leveraging Intelligence to Enhance Medication Management
After 18 tumultuous months, we’re excited to finally return to our first live event! We’re in Las Vegas this week attending HIMSS21, meeting with chief innovation officers, chief technology officers, vice presidents of IT, and clinical leaders to showcase how the Autonomous Pharmacy supports this year’s conference theme: Be the Change. The 2019 HIMSS U.S….
Building the Case for Dedicated 340B Program Management
The pressures of the last year have underscored the importance of the 340B program and its impact on hospital finances. Within this context, it may seem counterintuitive to ask for an investment in more staff to run your 340B program. Yet, based on our experience with covered entities that have a dedicated 340B program manager…
Balancing Lower U.S. Prescription Drug Prices And Innovation
Most Americans believe U.S. prescription drug prices are too high—a conclusion reinforced by almost 3 in 10 Americans reporting they go without prescribed medications because of cost. Indisputably, Americans pay much higher prices for brand-name drugs than people in other industrialized nations. Despite viewing drug prices as too high, most Americans value innovation, believing that new drugs improve people’s lives….
The Supreme Court Weighs In on Vaccine Mandates
On January 13, the Supreme Court allowed the Centers for Medicare and Medicaid Services’ (CMS) mandate requiring 10.4 million health care workers to be vaccinated against COVID-19 to go into effect, while blocking an Occupational Safety and Health Administration (OSHA) rule that would have required 84.2 million employees of large employers to be either vaccinated or masked and tested…
U.S. Dependence on Pharmaceutical Products From China
Last month, the U.S.-China Economic and Security Review Commission held a hearing on the United States’ growing reliance on China’s pharmaceutical products. The topic reminded me of a spirited discussion described in Bob Woodward’s book, Fear: Trump in the White House. In the discussion, Gary Cohn, then chief economic advisor to President Trump, argued against…
Novavax begins delivery of its long-delayed COVID-19 vaccine in Europe
The first doses of the Nuvaxovid vaccine have departed a distribution site in The Netherlands, bound for Austria, France and Germany, the company said on Wednesday. Supplies to other countries in the European Union are soon to follow. “The Novavax COVID-19 vaccine provides a differentiated option to bolster vaccination rates across Europe,” Stanley Erck, CEO of Novavax,…
Sanofi presses CDC experts to back its high-dose Fluzone shot for older adults
Not all flu shots are created equal. That’s the message Sanofi wants to convey as it pushes the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) to revise its influenza guidelines for older adults for the first time in more than a decade. Specifically, the drugmaker wants ACIP to update its…